PetCaseFinder

Peer-reviewed veterinary case report

Electrochemotherapy as extra treatment for dog eye melanoma

By Jean Carlos dos Santos da Luz et al.·Published in Veterinary Research Forum·2023·View original on Semantic Scholar

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Adjuvant electrochemotherapy of malignant ocular melanoma in a dog

Species:
dog

Plain-English summary

A 10-year-old mixed-breed dog was diagnosed with a malignant eye tumor called ocular melanoma. The dog underwent surgery to remove the tumor, and the veterinarian also used a treatment called electrochemotherapy (ECT) to help kill any remaining cancer cells. After about seven months of follow-up, the dog showed no signs of the tumor coming back, and the cloudy area on the cornea cleared up completely. This case suggests that ECT could be a promising option for treating similar eye tumors in dogs.

People also search for: dog eye tumor treatment · malignant melanoma in dogs · electrochemotherapy for dogs

Abstract

Melanocytoma and malignant melanoma are the most typical eye tumors in dogs and cats. Due to the presence of melanin, the general appearance is often highly pigmented in a nodular formation with well-defined borders. Electrochemotherapy (ECT) is a therapy combining reversible electroporation and anti-neoplastic drugs to enhance their cytotoxic effects through increasing cellular uptake by the electroporated tumor cells. In this article, the use of adjuvant ECT for the treatment of canine ocular melanoma is reported. The pre-surgical exams (blood count, renal and liver functions, echocardiogram, and electrocardiogram) were within the normal range, as were the chest radiography and abdominal ultrasound without signs of metastases. On the day of the surgery, an excisional biopsy of the tumor was performed without safety margins by keratectomy associated with conjunctivectomy and adjuvant ECT in the surgical site and peri-tumoral region. The animal was followed for approximately 7 months and remained without evidence of tumor recurrence. A complete resolution of corneal opacification was also observed. To our knowledge, this is the first report of the use of ECT in an ocular neoplasm. From a comparative oncology perspective, this report opens the way for future therapeutic approaches in superficial ocular cancers in veterinary and human medicine.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on Semantic Scholar: https://www.semanticscholar.org/paper/37901350